Caribou Biosciences (CRBU) Current Leases (2022 - 2026)

Caribou Biosciences (CRBU) has 5 years of Current Leases data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Current Leases fell 32.3% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $1.3 million, a 32.3% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 15.78% from the prior year.
• Current Leases for Q1 2026 stood at $1.3 million, up from $1.2 million in the prior quarter.
• Over the last five years, Current Leases for CRBU reached as high as $2.7 million in Q3 2025 and fell as low as $825000.0 in Q1 2022.
• Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.2 million in 2023.
• Across the five-year window, Current Leases soared 128.1% in 2025 and sank 32.3% in 2026, its largest moves.
• Year by year, Current Leases stood at $966000.0 in 2022, then grew by 24.22% to $1.2 million in 2023, then climbed by 18.83% to $1.4 million in 2024, then slipped by 15.78% to $1.2 million in 2025, then increased by 7.16% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Current Leases figures were $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $2.7 million in Q3 2025.